Clinical Bottom Line
Oral remdesivir and GS-441524 are both effective for non-effusive FIP; relapse monitoring needed.
Brostoff T, Pires J, Rose A, Cohen-Davidyan T, Castillo D, Murphy B, Reagan KL
This randomized, double-blind, noninferiority trial compared oral remdesivir versus GS-441524 for treating non-effusive feline infectious peritonitis (FIP), a fatal disease caused by feline coronavirus. Twenty cats were randomly assigned to receive e...